Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.

Item
http://www.wikidata.org/entity/Q37586721
Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: Review on the basis of in vitro and in vivo studies in rodents and humans.A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.In vivo models of alpha-synuclein transmission and propagation.The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications.Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy.Progressive Decline in Gray and White Matter Integrity in Parkinson's Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataLRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylationProteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease modelImmunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationMicroglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
P2860

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.

Item
http://www.wikidata.org/entity/Q37586721
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@en
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@nl
type
label
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@en
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@nl
prefLabel
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@en
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P932
P356
P1433
P1476
Anti-α-synuclein immunotherapy ...... enic model of synucleinopathy.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P932